Scott Terrillion, Sec'y, Chief Compliance & G.C at Cara Therapeutics, Inc. (CARA), sold 8,008 shares at $19.33 ($155K) on 2021-02-25, disclosed to the SEC on 2021-02-25.
Open-market sale of $155k CARA by Sec'y, Chief Compliance & G.C. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.33 | 4,004 | $77K | 50.0% |
| 2 | $19.33 | 4,004 | $77K | 50.0% |
| Total | $19.33 avg | 8,008 | $155K | 100% |
| Filing → |
| CARA | SELL | 2024-03-04 | $3K | — | Filing → |
| CARA | SELL | 2024-02-12 | $4K | — | Filing → |
| CARA | SELL | 2023-06-27 | $9K | — | Filing → |